References
- Wang J, Yu S, Li J, et al. Protective role of N-acetyl-l-tryptophan against hepatic ischemia-reperfusion injury via the RIP2/caspase-1/IL-1beta signaling pathway. Pharm Biol. 2019;57(1):385–391.
- Tang H, Qu E-Z, Li K, et al. Effect of hepatic artery spasm on a rat model of hepatic ischemia-reperfusion injury. J Ultrasound Med. 2019;38(3):597–604.
- Sikalias N, Karatzas T, Alexiou K, et al. Intermittent ischemic preconditioning protects against hepatic ischemia-reperfusion injury and extensive hepatectomy in steatotic rat liver. J Invest Surg. 2018;31(5):366–377.
- Zhang Y, Shen Q, Liu Y, et al. Hepatic ischemic preconditioning alleviates ischemia-reperfusion injury by decreasing TIM4 expression. Int J Biol Sci. 2018;14(10):1186–1195.
- Yuan M, Ge M, Yin J, et al. Isoflurane post-conditioning down-regulates expression of aquaporin 4 in rats with cerebral ischemia/reperfusion injury and is possibly related to bone morphogenetic protein 4/Smad1/5/8 signaling pathway. Biomed Pharmacother. 2018;97:429–438.
- Ko JS, Gwak MS, Kim GS, et al. The protective effect of ischemic preconditioning against hepatic ischemic-reperfusion injury under isoflurane anesthesia in rats. Transplant Proc. 2013;45(5):1704–1707.
- Lv X, Wang Z-M, Huang S-D, et al. Emulsified isoflurane preconditioning reduces lung injury induced by hepatic ischemia/reperfusion in rats. Int J Med Sci. 2011;8(5):353–361.
- Jiang S, Miao D, Wang M, et al. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/beta-catenin signaling axis. J Cell Mol Med. 2019;23(1):630–640.
- Tang J, Li Y, Liu K, et al. Exosomal miR-9-3p suppresses HBGF-5 expression and is a functional biomarker in hepatocellular carcinoma. Minerva Med. 2018;109(1):15–23.
- Liao X, Zhou S, Zong J, et al. Sevoflurane exerts protective effects on liver ischemia/reperfusion injury by regulating NFKB3 expression via miR-9-5p. Exp Ther Med. 2019;17(4):2632–2640.
- Bian T, Zheng L, Jiang D, et al. Overexpression of fibronectin type III domain containing 3B is correlated with epithelial-mesenchymal transition and predicts poor prognosis in lung adenocarcinoma. Exp Ther Med. 2019;17(5):3317–3326.
- Zhang X, Liu S, Hu T, et al. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology. 2009;50(2):490–499.
- Kong D, Ma W, Zhang D, et al. EYA1 promotes cell migration and tumor metastasis in hepatocellular carcinoma. Am J Transl Res. 2019;11(4):2328–2338.
- Cai C, Shi X, Korff S, et al. CD14 contributes to warm hepatic ischemia-reperfusion injury in mice. Shock. 2013;40(2):115–121.
- Yang W, Guo Q, Li J, et al. microRNA-124 attenuates isoflurane-induced neurological deficits in neonatal rats via binding to EGR1. J Cell Physiol. 2019;234(12):23017–23032.
- Nong K, Wang W, Niu X, et al. Hepatoprotective effect of exosomes from human-induced pluripotent stem cell-derived mesenchymal stromal cells against hepatic ischemia-reperfusion injury in rats. Cytotherapy. 2016;18(12):1548–1559.
- Li X, Wu Y, Zhang W, et al. Pre-conditioning with tanshinone IIA attenuates the ischemia/reperfusion injury caused by liver grafts via regulation of HMGB1 in rat Kupffer cells. Biomed Pharmacother. 2017;89:1392–1400.
- Yucel A, Aydogan MS, Ucar M, et al. Effects of apocynin on liver ischemia-reperfusion injury in rats. Transplant Proc. 2019;51(4):1180–1183.
- Liu Y, Ding Y, Nie Y, et al. EMP1 promotes the proliferation and invasion of ovarian cancer cells through activating the MAPK pathway. Onco Targets Ther. 2020;13:2047–2055.
- Yu S, Zheng J, Jiang Z, et al. Protective effect of N-acetylserotonin against acute hepatic ischemia-reperfusion injury in mice. Int J Mol Sci. 2013;14(9):17680–17693.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
- Zhou CZ, Wang RF, Cheng DL, et al. FLT3/FLT3L-mediated CD103(+) dendritic cells alleviates hepatic ischemia-reperfusion injury in mice via activation of treg cells. Biomed Pharmacother. 2019;118:109031.
- Li Y, Gao M, Xu L-N, et al. MicroRNA-142-3p attenuates hepatic ischemia/reperfusion injury via targeting of myristoylated alanine-rich C-kinase substrate. Pharmacol Res. 2020;156:104783.
- Zeng Z, Huang HF, Chen MQ, et al. Heme oxygenase-1 protects donor livers from ischemia/reperfusion injury: the role of Kupffer cells. World J Gastroenterol. 2010;16(10):1285–1292.
- Zhang YQ, Ding N, Zeng Y-F, et al. New progress in roles of nitric oxide during hepatic ischemia reperfusion injury. World J Gastroenterol. 2017;23(14):2505–2510.
- Peng L, Yin J, Wang S, et al. TGF-beta2/Smad3 signaling pathway activation through enhancing VEGF and CD34 ameliorates cerebral ischemia/reperfusion injury after isoflurane post-conditioning in rats. Neurochem Res. 2019;44(11):2606–2618.
- Ran K, Zou DQ, Xiao YY, et al. Effects of isoflurane preconditioning in the delayed phase on myocardial tumor necrosis factor alpha levels and caspase-3 protein expression in a rabbit model of ischemia-reperfusion injury. Genet Mol Res. 2015;14(3):7267–7273.
- Zhou Y, Peng DD, Chong H, et al. Effect of isoflurane on myocardial ischemia-reperfusion injury through the p38 MAPK signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(3):1342–1349.
- Qin Z, Lv E, Zhan L, et al. Intravenous pretreatment with emulsified isoflurane preconditioning protects kidneys against ischemia/reperfusion injury in rats. BMC Anesthesiol. 2014;14:28.
- Zhang L, Zhang Y, Hu R, et al. Isoflurane inhibits embryonic stem cell self-renewal and neural differentiation through miR-9/E-cadherin signaling. Stem Cells Dev. 2015;24(16):1912–1922.
- Yang S, Cai H, Hu B, et al. LncRNA SAMMSON negatively regulates miR-9-3p in hepatocellular carcinoma cells and has prognostic values. Biosci Rep. 2019;39(7). DOI:10.1042/BSR20190615
- Wang X, Zhao Z, Zhang W, et al. Long noncoding RNA LINC00968 promotes endothelial cell proliferation and migration via regulating miR-9-3p expression. J Cell Biochem. 2018. doi:10.1002/jcb.28103.
- Yue P, Jing L, Zhao X, et al. Down-regulation of taurine-up-regulated gene 1 attenuates inflammation by sponging miR-9-5p via targeting NF-kappaB1/p50 in multiple sclerosis. Life Sci. 2019;233:116731.
- Ou M, Zhang Y, Cui S, et al. Upregulated MiR-9-5p protects against inflammatory response in rats with deep vein thrombosis via inhibition of NF-kappaB p50. Inflammation. 2019;42(6):1925–1938.
- Jin Z, Ren J, Qi S. Exosomal miR-9-5p secreted by bone marrow-derived mesenchymal stem cells alleviates osteoarthritis by inhibiting syndecan-1. Cell Tissue Res. 2020;381(1):99–114.
- Chi L, Jiao D, Nan G, et al. miR-9-5p attenuates ischemic stroke through targeting ERMP1-mediated endoplasmic reticulum stress. Acta Histochem. 2019;121(8):151438.
- Yin H, He H, Shen X, et al. miR-9-5p inhibits skeletal muscle satellite cell proliferation and differentiation by targeting IGF2BP3 through the IGF2-PI3K/Akt signaling pathway. Int J Mol Sci. 2020;21(5):1655.
- Chen Y, Zhang S, Zhao R, et al. Upregulated miR-9-3p promotes cell growth and inhibits apoptosis in medullary thyroid carcinoma by targeting BLCAP. Oncol Res. 2017;25(8):1215–1222.